Semisynthetic Modification of Tau Protein with Di-Ubiquitin Chains for Aggregation Studies.

aggregation disulfide-coupling fibrils neurodegeneration polyubiquitin semisynthesis tau protein ubiquitination

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
20 Jun 2020
Historique:
received: 12 05 2020
revised: 19 06 2020
accepted: 19 06 2020
entrez: 25 6 2020
pubmed: 25 6 2020
medline: 17 2 2021
Statut: epublish

Résumé

Ubiquitin, a protein modifier that regulates diverse essential cellular processes, is also a component of the protein inclusions characteristic of many neurodegenerative disorders. In Alzheimer's disease, the microtubule associated tau protein accumulates within damaged neurons in the form of cross-beta structured filaments. Both mono- and polyubiquitin were found linked to several lysine residues belonging to the region of tau protein that forms the structured core of the filaments. Thus, besides priming the substrate protein for proteasomal degradation, ubiquitin could also contribute to the assembly and stabilization of tau protein filaments. To advance our understanding of the impact of ubiquitination on tau protein aggregation and function, we applied disulfide-coupling chemistry to modify tau protein at position 353 with Lys48- or Lys63-linked di-ubiquitin, two representative polyubiquitin chains that differ in topology and structure. Aggregation kinetics experiments performed on these conjugates reveal that di-ubiquitination retards filament formation and perturbs the fibril elongation rate more than mono-ubiquitination. We further show that di-ubiquitination modulates tau-mediated microtubule assembly. The effects on tau protein aggregation and microtubule polymerization are essentially independent from polyubiquitin chain topology. Altogether, our findings provide novel insight into the consequences of ubiquitination on the functional activity and disease-related behavior of tau protein.

Identifiants

pubmed: 32575755
pii: ijms21124400
doi: 10.3390/ijms21124400
pmc: PMC7352214
pii:
doi:

Substances chimiques

Disulfides 0
MAPT protein, human 0
Protein Aggregates 0
Ubiquitin 0
tau Proteins 0
Lysine K3Z4F929H6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Alzheimer's Association
ID : AARG-17-529221
Pays : United States
Organisme : University of Verona, Ricerca di Base
ID : -

Références

J Cell Mol Med. 2008 Apr;12(2):363-73
pubmed: 18266959
Cell. 2020 Feb 20;180(4):633-644.e12
pubmed: 32032505
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006247
pubmed: 22762014
Neuron. 1993 Jun;10(6):1151-60
pubmed: 8391280
Elife. 2019 Feb 05;8:
pubmed: 30720432
J Mol Biol. 2002 Dec 6;324(4):637-47
pubmed: 12460567
Nat Commun. 2015 Jan 20;6:6116
pubmed: 25600778
Hum Mol Genet. 2004 Apr 1;13(7):703-14
pubmed: 14962978
J Neurochem. 2003 Apr;85(1):115-22
pubmed: 12641733
Biochem Soc Trans. 2009 Oct;37(Pt 5):937-53
pubmed: 19754430
Nat Chem Biol. 2010 Apr;6(4):267-9
pubmed: 20208522
Angew Chem Int Ed Engl. 2020 Apr 16;59(16):6607-6611
pubmed: 32022419
Methods Enzymol. 2005;399:177-92
pubmed: 16338356
Nature. 2012 Dec 13;492(7428):266-70
pubmed: 23201676
Nature. 2017 Jul 13;547(7662):185-190
pubmed: 28678775
Curr Opin Chem Biol. 2004 Dec;8(6):610-6
pubmed: 15556404
Neurochem Int. 2011 Mar;58(4):458-71
pubmed: 21215781
FEBS Lett. 2017 Apr;591(7):979-990
pubmed: 28267209
J Biol Chem. 2014 Dec 12;289(50):34620-6
pubmed: 25349212
J Am Chem Soc. 2012 Mar 28;134(12):5468-71
pubmed: 22404520
Int J Biol Macromol. 2018 Mar;108:24-31
pubmed: 29175520
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5129-34
pubmed: 10805776
J Biol Chem. 2006 Apr 21;281(16):10825-38
pubmed: 16443603
Bioessays. 2017 Jun;39(6):
pubmed: 28493408
J Am Chem Soc. 2017 Apr 12;139(14):4971-4986
pubmed: 28328208
Chemistry. 2018 Apr 17;24(22):5911-5919
pubmed: 29446497
Nat Rev Mol Cell Biol. 2012 Jul 23;13(8):508-23
pubmed: 22820888
Biochemistry. 2001 May 22;40(20):6036-46
pubmed: 11352739
Nat Rev Neurosci. 2016 Jan;17(1):5-21
pubmed: 26631930
Annu Rev Biochem. 2012;81:167-76
pubmed: 22663079
Essays Biochem. 2019 Apr 23;63(1):147-156
pubmed: 30940742
Annu Rev Biochem. 2017 Jun 20;86:123-128
pubmed: 28654326
Front Aging Neurosci. 2019 Dec 06;11:324
pubmed: 31866849
Front Mol Neurosci. 2014 Jul 31;7:70
pubmed: 25132814
Angew Chem Int Ed Engl. 2019 Feb 4;58(6):1616-1620
pubmed: 30549369
Phys Chem Chem Phys. 2016 Feb 17;18(8):5771-88
pubmed: 26422168
Nat Chem Biol. 2010 Apr;6(4):270-2
pubmed: 20208521
Science. 2003 Apr 18;300(5618):486-9
pubmed: 12702875
Methods Mol Biol. 2005;299:35-51
pubmed: 15980594
Science. 1987 Mar 27;235(4796):1641-4
pubmed: 3029875
J Biomed Sci. 2019 Oct 21;26(1):80
pubmed: 31630678
Biochim Biophys Acta. 2014 Sep;1842(9):1527-38
pubmed: 24905733
Nat Med. 2014 Nov;20(11):1242-53
pubmed: 25375928
Chem Soc Rev. 2011 Mar;40(3):1623-34
pubmed: 21049125
Angew Chem Int Ed Engl. 2020 Mar 2;59(10):4059-4067
pubmed: 31863676
Mol Neurobiol. 2016 Mar;53(2):905-931
pubmed: 25561438
Phys Chem Chem Phys. 2015 Mar 28;17(12):7606-18
pubmed: 25719972
J Biol Chem. 2004 Feb 20;279(8):7055-63
pubmed: 14645257

Auteurs

Francesca Munari (F)

Department of Biotechnology, University of Verona, 37128 Verona, Italy.

Carlo Giorgio Barracchia (CG)

Department of Biotechnology, University of Verona, 37128 Verona, Italy.

Francesca Parolini (F)

Department of Biotechnology, University of Verona, 37128 Verona, Italy.

Roberto Tira (R)

Department of Biotechnology, University of Verona, 37128 Verona, Italy.

Luigi Bubacco (L)

Department of Biology, University of Padova, 35121 Padova, Italy.

Michael Assfalg (M)

Department of Biotechnology, University of Verona, 37128 Verona, Italy.

Mariapina D'Onofrio (M)

Department of Biotechnology, University of Verona, 37128 Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH